What ophthalmologists wish you knew about platelet-derived therapies
Who are the best patients? What are the outcomes like? What’s in store for the future? Three physicians answered these questions and more as they pertain to platelet-derived ocular surface therapies, giving insights on what they wish ophthalmologists knew about these products.
